In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Adma Biologics Inc (NASDAQ: ADMA) closed at $17.68 in the last session, up 3.94% from day before closing price of $17.01. In other words, the price has increased by $3.94 from its previous closing price. On the day, 4.51 million shares were traded.
Ratios:
We take a closer look at ADMA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 40.52 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.64. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 5.97. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.23.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 22 ’24 when Tade Brad L. sold 15,000 shares for $21.15 per share. The transaction valued at 317,250 led to the insider holds 199,433 shares of the business.
Grossman Adam S sold 48,967 shares of ADMA for $1,033,204 on Nov 22 ’24. The President and CEO now owns 1,989,007 shares after completing the transaction at $21.10 per share. On Nov 22 ’24, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 48,967 shares for $21.30 each.
Valuation Measures:
As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.71, and their Forward P/E ratio for the next fiscal year is 17.80. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.70. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.80 while its Price-to-Book (P/B) ratio in mrq is 11.99.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $5.68. The 50-Day Moving Average of the stock is 5.58%, while the 200-Day Moving Average is calculated to be 10.42%.
Shares Statistics:
A total of 236.62M shares are outstanding, with a floating share count of 228.00M. Insiders hold about 3.55% of the company’s shares, while institutions hold 86.69% stake in the company.
